Publication date: Sep 02, 2024
This study evaluated the relationship of non-invasive arterial stiffness parameters with an individual 10-year risk of fatal and non-fatal atherosclerotic cardiovascular disease (ASCVD) events in the cohort post-coronavirus disease 2019 (COVID-19). The study group included 203 convalescents aged 60. 0 (55. 0-63. 0) and 115 (56. 7%) women. The ASCVD risk was assessed as low to moderate to very high based on medical history (for 62 participants with pre-existing ASCVD/diabetes/chronic kidney disease in the entire cohort) or calculated in percentages using the Systemic Coronary Risk Evaluation 2 (SCORE2) algorithm based on age, sex, smoking status, systolic blood pressure (BP), and non-high-density lipoprotein cholesterol (for 141 healthy participants). The stiffness index (SI) and reflection index (RI) measured by photoplethysmography, as well as pulse pressure (PP), calculated as the difference between systolic and diastolic BP, were markers of arterial stiffness. Stiffness parameters increased significantly with the increase in ASCVD risk in the entire cohort. In 30 (14. 8%) patients in the low- to moderate-risk group, the median SI was 8. 07 m/s (7. 10-8. 73), RI 51. 40% (39. 40-65. 60), and PP 45. 50 mmHg (40. 00-57. 00); in 111 (54. 7%) patients in the high-risk group, the median SI was 8. 70 m/s (7. 40-10. 03), RI 57. 20% (43. 65-68. 40), and PP 54. 00 mmHg (46. 00-60. 75); and in 62 (30. 5%) patients in the very-high-risk group, the median was SI 9. 27 m/s (7. 57-10. 44), RI 59. 00% (50. 40-72. 40), and PP 60. 00 mmHg (51. 00-67. 00). In healthy participants, the SI ≤ 9. 0 m/s (sensitivity of 92. 31%, area under the curve [AUC] 0. 686, p < 0. 001) based on the receiver operating characteristics was the most sensitive variable for discriminating low to moderate risk, and PP > 56. 0 mmHg (sensitivity of 74. 36%, AUC 0. 736, p < 0. 001) was used for discriminating very high risk. In multivariate logistic regression, younger age, female sex, PP ≤ 50 mmHg, SI ≤ 9. 0 m/s, and triglycerides < 150 mg/dL had the best relationship with low to moderate SCORE2 risk. In turn, older age, currently smoking, PP > 56. 0 mmHg, RI > 68. 6%, and diastolic BP ≥ 90 mmHg were related to very high SCORE2 risk. In conclusion, arterial stiffness is significantly related to ASCVD risk in post-COVID-19 patients and can be helpful as a single risk marker in everyday practice. Cut-off points for arterial stiffness parameters determined based on SCORE2 may help make individual decisions about implementing lifestyle changes or pharmacological treatment of ASCVD risk factors.
Open Access PDF
Concepts | Keywords |
---|---|
Coronavirus | arterial stiffness |
Diabetes | atherosclerotic cardiovascular diseases |
Pharmacological | COVID-19 disease |
Photoplethysmography | risk prediction |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Arterial Stiffness |
disease | MESH | Cardiovascular Disease |
disease | MESH | COVID-19 |
disease | IDO | history |
disease | MESH | chronic kidney disease |
disease | IDO | algorithm |
disease | IDO | blood |
drug | DRUGBANK | Cholesterol |
disease | MESH | lifestyle |
disease | MESH | Cardiovascular Risk Score |
disease | MESH | Heart Failure |
drug | DRUGBANK | Coenzyme M |
disease | MESH | death |
disease | MESH | chronic illnesses |
disease | MESH | dyslipidemia |
disease | MESH | hypertension |
disease | MESH | arthritis |
disease | MESH | complications |
disease | MESH | long COVID |
disease | MESH | syndrome |
disease | MESH | infection |
disease | MESH | oxidative stress |
disease | IDO | production |
disease | MESH | inflammation |
disease | MESH | arteriosclerosis |
disease | MESH | hyperglycemia |
disease | MESH | hyperlipidemia |
disease | MESH | obesity |
drug | DRUGBANK | Cysteamine |
disease | MESH | myocardial infarction |